Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
A structured maintenance plan can help reduce regain risk, but no approach guarantees complete stability
Oral ferroportin inhibitor VIT-2763: first-in-human, phase 1 study in healthy volunteers
The manufacturer publishes a list price and offers savings programs that may reduce cost for eligible patients, with separate options that may help those without coverage
Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and IV clusters
Key endpoints included change in glycated haemoglobin (HbA 1c ) and body weight
US$ 21.82
US$ 23.12
US$ 26.10
US$ 24.64
US$ 24.33
US$ 26.82
US$ 22.54
US$ 29.91
US$ 22.65
